. Home Research Career News Services Contact us Services The group Career Contacts COVID-19 The Group >> History >> 1997-2001: Expansion of the technological portfolio Search >> Services The group Site Privacy Policy Eurofins in the world Vision, Mission, Values Historical 1987-1997: Launch phase 1997-2001: Expansion of the technological portfolio 2002-2004: Infrastructure development From 2005: Towards a benchmark global player Career Contacts COVID-19 Expansion of the technological portfolio 1997 - 2001 Expansion of the technological portfolio During this period, Eurofins' priority was to acquire flagship laboratories equipped with unique technologies and know-how with a potential for international influence. In addition, the Group has established itself in 8 new countries and has extended its network to more than 50 laboratories. The Group has built leadership positions in its 3 core businesses (food, pharmaceutical and environmental analyzes) but also in key market segments such as genomic information and contaminant analysis. Subsequently, these new services enabled the Group to gain new major clients in the pharmacy and mass distribution sectors. This expansion program was initially financed by the IPO on the Paris Stock Exchange in 1997 followed by a double listing in Frankfurt in 2000. Contact us Home page | Search | Career | News | Contact us | Investors Sitemap | Cookie Notice | Global Eurofins Cookie Preferences © Eurofins France Last updated: Wednesday, August 1, 2018 About Cookies on This Site By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy Accept All Cookies Adjust Preferences